The Virtual 2021 Ryan White HIV/AIDS Program CLINICAL CONFERENCE


Allison Agwu, MD, ScM
The Johns Hopkins University
Wendy Armstrong, MD
Wendy Armstrong, MD
Emory University
Roger J. Bedimo, MD, MS
University of Texas Southwestern Medical Center
Susan P. Buchbinder, MD
University of California San Francisco
Connie L. Celum, MD, MPH
University of Washington
Laura W. Cheever, MD, ScM
The Health Resources and Services Administration
Francine Cournos, MD
Francine Cournos, MD
Columbia University
Susan Cu-Uvin, MD
Susan Cu-Uvin, MD
Brown University
Judith S. Currier, MD
University of California Los Angeles
Jodie Dionne-Odom, MD
University of Alabama at Birmingham
Monica Gandhi, MD, MPH
University of California San Francisco
Rajesh T. Gandhi, MD
Harvard Medical School
Khalil G. Ghanem, MD, PhD
Khalil G. Ghanem, MD, PhD
Johns Hopkins University School of Medicine
Meredith Greene, MD
Meredith Greene, MD
University of California San Francisco
Rachel Bender Ignacio, MD, MPH
University of Washington
Nadine Kaslow
Nadine J. Kaslow, PhD
Emory University
Jennifer J. Kiser, PharmD, PhD
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
Raphael J. Landovitz, MD
University of California Los Angeles
James Raper
James Raper, PhD, DSN, CRNP, JD
University of Alabama at Birmingha
Michael S. Saag, MD
University of Alabama at Birmingham
Melanie Thompson, MD
Melanie A. Thompson, MD
AIDS Research Consortium of Atlanta
Ronald Wilcox, MD
The Health Resources and Services Administration
Timothy J. Wilkin, MD, MPH
Weill Cornell Medicine


Marcus Conant, MD
San Francisco AIDS Foundation
Kathleen A. Clanon, MD
Alameda Care Connect
Alison Moed, RN
San Francisco General Hospital
Michael Reyes, MD
University of California San Francisco
Paul A. Volberding, MD
University of California San Francisco

October 3 - 6, 2021

The virtual conference will be hosted through this activity page. You will need your IAS–USA login information to access all virtual content.

Due to the rapid rise of COVID-19 delta variant infections, we have come to the difficult decision that it is unsafe and impractical to have the in-person component of the 2021 RWHAP CLINICAL CONFERENCE. Our first and foremost concern is to ensure our attendees’ health and safety and decided the safest option is to only have the virtual component of the conference. The conference dates will remain the same and the updated agenda, including the updated conference hours, is available in this activity page.

For more information, click here.

For FAQs, click here.


virtual 2021 RWHAP CLINICAL CONFERENCE Description

The virtual Ryan White HIV/AIDS Program (RWHAP) CLINICAL CONFERENCE will will be held from Sunday, October 3 to Wednesday, October 6. The virtual RWHAP CLINICAL CONFERENCE will provide state-of-the-art updates on research, care, and treatment issues in the medical management of HIV infection for experienced HIV clinical decision makers.

The virtual RWHAP CLINICAL CONFERENCE is planned with and supported by the HIV/AIDS Bureau, Health Resources and Services Administration of the US Department of Health and Human Services (HRSA) and is sponsored and organized by the International Antiviral Society-USA (IAS-USA). This conference is coordinated through the RWHAP AIDS Education and Training Centers (AETC) clinician training network. A mix of lectures, case-based interactive presentations, and small-group workshop breakout sessions will be held during the 4 days of the virtual RWHAP CLINICAL CONFERENCE.

Who Should Attend

Attendance is limited to 600 HIV physicians, nurse practitioners, and physician assistants in Ryan White HIV/AIDS Program (RWHAP)-funded clinics and programs (specifically for in part A, B, C, and D). The virtual RWHAP CLINICAL CONFERENCE will offer an increased limit of virtual registrations for RNs and PharmDs who are the primary clinical care decision makers in their RWHAP-funded clinics or programs and is restricted to up to 7 attendees per size of the clinic. There is no registration fee to attend.

Learning Objectives

The educational objectives for the virtual 2021 RWHAP CLINICAL CONFERENCE are designed and developed based on the identified needs and knowledge gaps of the attendees.

On completion of the virtual 2021 RWHAP CLINICAL CONFERENCE, participants will be able to:

  • Describe the new aspects to the Ryan White HIV/AIDS Program
  • Identify situations in which the choice of antiretroviral regimen should consider particular clinical circumstances, such as comorbid conditions, coinfections, pregnancy, and issues in older patients
  • Describe the most current data on currently available and investigational new antiretroviral drugs, formulations, and strategies
  • Initiate and monitor HIV prevention intervention strategies, including the use of preexposure prophylaxis (PrEP), in individuals at risk for HIV infection
  • Describe the current epidemiology, clinical presentations, and management of the most common sexually transmitted infections (STIs) in adults with HIV infection and in special populations such as adolescents
  • Detect, manage, and prevent common comorbidities occurring in the aging population of persons with HIV infection, including how to manage and prevent polypharmacy
  • Describe the current understanding of COVID-19 in people with HIV
  • Identify ways to prevent HIV-related comorbidities in adolescents
  • Detect and address depression in patients with HIV, as well as practitioner and staff burnout
  • Describe the current best practices of perinatal HIV care and prevention
  • Describe barriers and strategies for engaging out-of-care patients with HIV
  • Describe the risk factors and screening recommendations for non-AIDS cancers in people with HIV
  • Describe challenges and opportunities for utilizing telemedicine for the prevention and treatment of HIV

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 16.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 16.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Academy of Family Physicians Credits

These activities are eligible for AAFP credit, see final AAFP activity announcement for specific details.

Nursing Credits

These activities are eligible for ANCC credit, see final CNE activity announcement for specific details.

Pharmacy Credits

Accreditation Council for Pharmacy Education logoThese activities are eligible for ACPE credit, see final CPE activity announcement for specific details.

Grant Support

This conference is funded by Health Resources and Services Administration (HRSA) of the US Department of Health and Human Services (HHS) under grant number U1OHA28686 (AIDS Education and Training Center National Coordinating Resource Center) awarded François-Xavier Bagnoud Center from the Rutgers University School of Nursing with a sub award to International Antiviral Society–USA (IAS–USA) to sponsor this CME activity.

Apply to Attend

Applications must be approved to attend the virtual 2021 RWHAP CLINICAL CONFERENCE. If you do not receive an application status email notification within 2 business days of submitting your application, please check your spam folder. Otherwise, please email